NetworkNewsBreaks

WednesdayJan 22, 2020 10:58 am

NetworkNewsBreaks – InnerScope Hearing Technologies (INND) Announces Walmart.com Launch of HearingVite(TM) Dietary Hearing Supplement

InnerScope Hearing Technologies (OTCQB: INND), a manufacturer and Direct-to-Consumer distributor/retailer of FDA-registered hearing aids, personal sound amplifiers products, hearing related treatment therapies, doctor-formulated dietary hearing supplements and proprietary CBD oil, today announced the launch on Walmart.com of HearingVite(TM). According to the update, InnerScope's HearingVite(TM) is a doctor-formulated dietary supplement plus multivitamin designed for maintaining proper hearing health. “We are proud to offer InnerScope's HearingVite(TM) on Walmart.com,” InnerScope CEO Matthew Moore said in the news release. “With the U.S. aging population continuing to grow, especially among the Baby Boomer population, so does the age-related hearing-impaired population continues to increase. We believe…

Continue Reading

WednesdayJan 22, 2020 10:06 am

NetworkNewsBreaks – Sugarmade, Inc. (SGMD) Places Hold on Reverse Split, Plans Entry into Regulated and Licensed Portion of Cannabis Marketplace

Sugarmade (OTCQB: SGMD) today announced that it has placed a hold on plans to complete a reverse split of its common shares. Per the update, pending a vote by its board of directors, management believes temporarily holding or canceling the reverse split may be the best future course of action. In addition, Sugarmade announced its planned entry into the regulated and licensed portion of the cannabis marketplace, with an emphasis on the California distribution and retail sectors. “For at least the time being, we do not see a reason to move forward with the reverse stock split. However, we reserve…

Continue Reading

WednesdayJan 22, 2020 10:00 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Provide Patented DehydraTECH(TM) to Cannadips’ Cannabis Products in California and Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has reached a new definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips' cannabis products, both in its current California market and across the United States. According to the update, Lexaria's DehydraTECH fast-acting, high-absorption technology is perfectly suited to improve consumer satisfaction and the dipping experience. Terpene-rich multi spectrum oils are base ingredients of Cannadips THC, and DehydraTECH is able to reduce throat irritation normally associated with some terpenes. Inferior products utilize less efficacious cannabis isolate without terpenes that lack the entourage…

Continue Reading

WednesdayJan 22, 2020 9:30 am

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Closes Fully Subscribed Private Placement

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) on Tuesday announced the closing of a non-brokered, fully subscribed private placement of 7,692,307 units at a price of $0.065 each for total proceeds of $500,000. Each unit consists of one common share and one half of one common share purchase warrant of the company. Each warrant authorizes the holder to receive, for no additional consideration, one common share, subject to adjustments, at an exercise price of $0.15 for 24 months from the date of issuance. All securities issued are subject to a 4-month and one day hold period in Canada. PowerBand…

Continue Reading

WednesdayJan 22, 2020 9:21 am

NetworkNewsBreaks – Grapefruit Boulevard Investments, Inc. (IGNG) Files Amendment No. 1 to Registration Statement

Grapefruit Boulevard Investments (“GBI”), a licensed and fully compliant California based cannabis distribution and manufacturing company and a wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG) (collectively “Grapefruit”), this morning announced that it has filed Amendment No. 1 to its Registration Statement on Form S-1 that was originally filed on July 28, 2019 regarding conversions of convertible notes issued to the company’s institutional investor Auctus Fund, LLC. “We are very pleased to file the Amendment which puts us back on track to complete the Auctus transaction. Pursuant to the terms of our Agreements with Auctus, immediately upon effectiveness of the…

Continue Reading

TuesdayJan 21, 2020 2:10 pm

NetworkNewsBreaks – Jerrick Media Holdings Inc. (JMDA) CEO Discusses Future Uplisting in Weekly Update

Jerrick Media Holdings (OTCQB: JMDA), a holding company that gives technology products the resources and opportunities to make ideas a reality, recently published a weekly update from the company’s CEO Jeremy Frommer discussing relevant news, updates and insights. Among other highlights in this week’s update, Frommer discussed the company’s strategies for the year, including a planned uplisting from the OTCQB to the NASDAQ Capital Market. “As we approach the uplisting period, based on all the workflows my team is managing, including S-1 paperwork, NASDAQ application documents, financing and revenue generation, I can see the uplisting window narrowing to the last…

Continue Reading

TuesdayJan 21, 2020 1:28 pm

NetworkNewsBreaks – Namaste Technologies Inc.’s (TSX.V: N) (OTCQB: NXTTF) Position to Capitalize on Changing Cannabis Industry Highlighted in technical420 Article

Namaste Technologies (TSX.V: N) (OTCQB: NXTTF), an online platform for cannabis products, accessories, and responsible education, was highlighted in a recent article by Anthony Varrell on technical420 titled ‘Namaste Technologies Is On Track To Be One Of The Biggest Turnaround Stories of 2020’. Among other highlights, the article discusses some recent key achievements by the company as well as its strategy moving forward. “Through CannMart, Namaste is well positioned to capitalize on the cannabis 2.0 opportunity, and we find this to be significant. The company expects to start selling several new cannabis derivative products in March and to submit up…

Continue Reading

TuesdayJan 21, 2020 11:26 am

NetworkNewsBreaks – InnerScope Hearing Technologies (INND) Achieves Revenue Growth of 318% Year Over Year

InnerScope Hearing Technologies Inc. (OTCQB: INND), a manufacturer and Direct-to-Consumer ("DTC") distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products ("Hearing Products"), Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CBD Oil ("Hearing Health Products") (collectively "Hearing Product Portfolio”), today announced its unaudited annual revenue results ended December 31, 2019 of $1,034,791 (includes customer orders not yet delivered). According to the update, the results reflect a year over year revenue growth of 318% over the annual revenue booked ended December 31, 2018. In addition, InnerScope’s unaudited fourth quarter revenue results ended December 31, 2019 (Q4 2019) increased 31%…

Continue Reading

TuesdayJan 21, 2020 10:37 am

NetworkNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries, Inc. Secures $1.2M of Tolling Revenue for February

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, together with its wholly owned subsidiary, Khrysos Industries, Inc., today announced that its tolling operation within its 82,000 square foot facility in Orlando, Florida has filled 42% of its available capacity generating $1.2 million of revenue for February tolling production. According to the update, Khrysos Industries tolling operation represents one revenue segment of Youngevity's hemp enterprise. “Our current capacity for our tolling operations, at current prices, provides us the opportunity to generated monthly revenue of…

Continue Reading

TuesdayJan 21, 2020 10:28 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Receipt of U.S. FDA Fast Track Designation for Immunogene Therapy that Targets Lung Cancer

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, nonviral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that the U.S Food and Drug Administration (FDA) has granted Fast Track Designation for Genprex’s Oncoprex(TM) immunogene therapy in combination with EGFR inhibitor osimertinib (AstraZeneca’s Tagrisso(R)). Tagrisso(R), with worldwide sales of $1.86 billion in 2018 and $2.31 billion in the first 9 months of 2019, is currently AstraZeneca’s highest grossing product for the treatment of non-small cell lung cancer (NSCLC) patients with EFGR mutations that progressed after treatment with osimertinib alone. Genprex has treated more…

Continue Reading